PFIZER INC — Director's Dealing 2011

Sep 8, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ICAGEN INC (ICGN)
CIK: 0000902622
Period of Report: 2011-09-02

Reporting Person: PFIZER INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-09-02	Common Stock	P	4617045	$6	Acquired	4617045	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1067015	Direct

Footnotes

F1: Represents shares purchased (including approximately 688,100 shares subject to guarantees of delivery) by Eclipse Acquisition Corp. ("Purchaser"), a wholly-owned subsidiary of Pfizer Inc. ("Parent"), in a tender offer. These shares are owned directly by Purchaser and may also be deemed to be indirectly beneficially owned by Parent.

F2: Includes 1,067,015 previously directly owned by Parent.